Literature DB >> 27094041

Evaluation of ECG-gated [(11)C]acetate PET for measuring left ventricular volumes, mass, and myocardial external efficiency.

Nils Henrik Hansson1, Lars Tolbod2, Hendrik Johannes Harms2, Henrik Wiggers3, Won Yong Kim3,4, Esben Hansen4,5, Tomas Zaremba3, Jørgen Frøkiær2, Steen Jakobsen2, Jens Sørensen2.   

Abstract

BACKGROUND: Noninvasive estimation of myocardial external efficiency (MEE) requires measurements of left ventricular (LV) oxygen consumption with [(11)C]acetate PET in addition to LV stroke volume and mass with cardiovascular magnetic resonance (CMR). Measuring LV geometry directly from ECG-gated [(11)C]acetate PET might enable MEE evaluation from a single PET scan. Therefore, we sought to establish the accuracy of measuring LV volumes, mass, and MEE directly from ECG-gated [(11)C]acetate PET.
METHODS: Thirty-five subjects with aortic valve stenosis underwent ECG-gated [(11)C]acetate PET and CMR. List mode PET data were rebinned into 16-bin ECG-gated uptake images before measuring LV volumes and mass using commercial software and compared to CMR. Dynamic datasets were used for calculation of mean LV oxygen consumption and MEE.
RESULTS: LV mass, volumes, and ejection fraction measured by CMR and PET correlated strongly (r = 0.86-0.92, P < .001 for all), but were underestimated by PET (P < .001 for all except ESV P = .79). PET-based MEE, corrected for bias, correlated fairly with PET/CMR-based MEE (r = 0.60, P < .001, bias -3 ± 21%, P = .56). PET-based MEE bias was strongly associated with LV wall thickness.
CONCLUSIONS: Although analysis-related improvements in accuracy are recommended, LV geometry estimated from ECG-gated [(11)C]acetate PET correlate excellently with CMR and can indeed be used to evaluate MEE.

Entities:  

Keywords:  Myocardial external efficiency; PET imaging; magnetic resonance imaging; metabolism: PET

Mesh:

Substances:

Year:  2016        PMID: 27094041     DOI: 10.1007/s12350-015-0331-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  29 in total

Review 1.  Myocardial energetics and efficiency: current status of the noninvasive approach.

Authors:  Paul Knaapen; Tjeerd Germans; Juhani Knuuti; Walter J Paulus; Pieter A Dijkmans; Cornelis P Allaart; Adriaan A Lammertsma; Frans C Visser
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

2.  The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man.

Authors:  R J BING; M M HAMMOND
Journal:  Am Heart J       Date:  1949-07       Impact factor: 4.749

3.  Measurement of left ventricular volumes and function with O-15-labeled carbon monoxide gated positron emission tomography: comparison with magnetic resonance imaging.

Authors:  Hadassa A Hofman; Paul Knaapen; Ronald Boellaard; Olga Bondarenko; Marco J W Götte; Willem G van Dockum; Cees A Visser; Albert C van Rossum; Adriaan A Lammertsma; Frans C Visser
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Measurement of myocardial blood flow with PET using 1-11C-acetate.

Authors:  R R Sciacca; O Akinboboye; R L Chou; S Epstein; S R Bergmann
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

6.  Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging.

Authors:  Wolfgang M Schaefer; Claudia S A Lipke; Bernd Nowak; Hans Juergen Kaiser; Arno Buecker; Gabriele A Krombach; Udalrich Buell; Harald P Kühl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-15       Impact factor: 9.236

7.  The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy.

Authors:  R S Beanlands; W F Armstrong; R J Hicks; J Nicklas; C Moore; G D Hutchins; H G Wolpers; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

8.  Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.

Authors:  Stefan A J Timmer; Tjeerd Germans; Marco J W Götte; Iris K Rüssel; Pieter A Dijkmans; Mark Lubberink; Jurrien M ten Berg; Folkert J ten Cate; Adriaan A Lammertsma; Paul Knaapen; Albert C van Rossum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

9.  Gated F-18 FDG PET for assessment of left ventricular volumes and ejection fraction using QGS and 4D-MSPECT in patients with heart failure: a comparison with cardiac MRI.

Authors:  Yan Li; Li Wang; Shi-Hua Zhao; Zuo-Xiang He; Dao-Yu Wang; Feng Guo; Wei Fang; Min-Fu Yang
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

10.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-01       Impact factor: 5.364

View more
  7 in total

1.  Tight software, methodological/physiological variation, less so.

Authors:  Henry Gewirtz
Journal:  J Nucl Cardiol       Date:  2018-02-16       Impact factor: 5.952

2.  Repeatable and reproducible measurements of myocardial oxidative metabolism, blood flow and external efficiency using 11C-acetate PET.

Authors:  Kai Yi Wu; Vincent Dinculescu; Jennifer M Renaud; Shin-Yee Chen; Ian G Burwash; Lisa M Mielniczuk; Rob S B Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2018-02-16       Impact factor: 5.952

3.  Myocardial Oxygen Consumption and Efficiency in Aortic Valve Stenosis Patients With and Without Heart Failure.

Authors:  Nils Henrik Stubkjær Hansson; Jens Sörensen; Hendrik Johannes Harms; Won Yong Kim; Roni Nielsen; Lars P Tolbod; Jørgen Frøkiær; Kirsten Bouchelouche; Karen Kaae Dodt; Inger Sihm; Steen Hvitfeldt Poulsen; Henrik Wiggers
Journal:  J Am Heart Assoc       Date:  2017-02-06       Impact factor: 5.501

4.  Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients-a description of the DAPACARD study.

Authors:  Axel Åkerblom; Jonas Oldgren; Aino Latva-Rasku; Lars Johansson; Vera Lisovskaja; Cecilia Karlsson; Jan Oscarsson; Pirjo Nuutila
Journal:  Ups J Med Sci       Date:  2019-01-08       Impact factor: 2.384

5.  Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis.

Authors:  Tor Skibsted Clemmensen; Jens Soerensen; Nils Henrik Hansson; Lars Poulsen Tolbod; Hendrik J Harms; Hans Eiskjær; Fabian Mikkelsen; Henrik Wiggers; Niels Frost Andersen; Steen Hvitfeldt Poulsen
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

6.  Automatic calculation of myocardial external efficiency using a single 11C-acetate PET scan.

Authors:  Hendrik J Harms; Nils Henrik S Hansson; Tanja Kero; Tomasz Baron; Lars P Tolbod; Won Y Kim; Jørgen Frøkiær; Frank A Flachskampf; Henrik Wiggers; Jens Sörensen
Journal:  J Nucl Cardiol       Date:  2018-06-26       Impact factor: 5.952

7.  Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.

Authors:  Roni Nielsen; Niels Møller; Lars C Gormsen; Lars Poulsen Tolbod; Nils Henrik Hansson; Jens Sorensen; Hendrik Johannes Harms; Jørgen Frøkiær; Hans Eiskjaer; Nichlas Riise Jespersen; Søren Mellemkjaer; Thomas Ravn Lassen; Kasper Pryds; Hans Erik Bøtker; Henrik Wiggers
Journal:  Circulation       Date:  2019-04-30       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.